Patanjali Share Price Target 2025, 2026, 2027 to 2030

Do you want to know the Patanjali share price target for the year 2025? Here, you will get a detailed analysis of the company’s financial performance, historical data, and price target for the year 2025, 2026, 2027, 2028, 2029, and 2030 provided by the market experts and analysts.

About Patanjali Limited

Patanjali Ayurved is an Indian company that makes herbal medicines, food items, and personal care products using natural ingredients. The company sells things like herbal shampoos, toothpaste, juices, and hair oil. It has many stores and Centers where people can buy products or take advice about health. Patanjali also runs wellness Centers where yoga and natural therapies are used to help people feel well. The company aims to bring ancient wisdom and healthy products to everyone.

Patanjali Fundamentals

• Market Cap: ₹70,473.04Cr.
• P/E Ratio: 54.15
• Book Value: ₹313.69
• Dividend Yield: 0.51%
• ROE: 7.64%
• ROCE: 11.15%
• 52-Week High: ₹2,030
• 52-Week Low: ₹1,554.65

Patanjali Shareholding Pattern

• Promoter: 69.54%
• FII: 0%
• DII: 22.13%
• Public: 8.42%
• Others: 0%

Patanjali Share Price Historical Data

Patanjali Share Price Target 2025 to 2030

Year Wise Analysis

The brand has become very popular because it focuses on natural and Ayurvedic products that many people trust. Over the years, Patanjali has expanded its business quickly, reaching customers across cities, towns, and villages. Many investors believe the company has strong growth potential, and experts have predicted its possible share prices for the coming years.

In 2025, the Patanjali share price is expected to be around ₹2,210. If the company continues to grow, it could reach ₹2,675 in 2026. By 2027, the price may rise to ₹3,010. In 2028, it might touch ₹3,435, followed by ₹4,330 in 2029. Looking ahead to 2030, experts believe it could reach ₹5,325.

These predictions show a positive outlook for the company, but they are only estimates and not guaranteed. The actual share price can change depending on market conditions, customer demand, and how well the company performs. That’s why investors should always research carefully and make wise investment decisions.

Also Read: ICICI Bank Share Price Target 2025, 2026, 2027 to 2030

Patanjali Company Financials

In the financials section of Patanjali Ayurved Limited, we will discuss its income statement and balance sheet, so you can decide whether this stock is good for you or not for trade.

Patanjali Income Statement

This year, the company earned ₹96.92 billion by selling its products and services, which is more than last year. After covering all its costs, it made ₹3.59 billion in profit—which is a big improvement! That means the company is keeping more of what it earns, which is a good sign. For every ₹100 it earned, it kept around ₹4. Each share made ₹9.91 for its owner. Even though it spent more to run things, it still did better overall and grew nicely.

Patanjali Balance Sheet

The company owns things worth ₹155.17 billion, like its buildings, machines, and money. Out of that, it owes ₹41.46 billion to others. It has ₹4.34 billion in cash and short-term savings, which is less than last year, but it still has a strong base. With about 362 million shares in total, each share is worth much more now. The company also gets good returns from what it invests, which shows smart money use.

Patanjali Peer Companies

The peer companies of Patanjali which are in tough competition are Hindustan Unilever, Dabur India, ITC Limited, Marico Limited, Nestlé India, Emami Limited, Baidyanath Group, Colgate‑Palmolive India, Zydus Wellness, Himalaya Herbal Healthcare, Organic India, and Forest Essentials

F&Q

Rishi Gupta